tetano
Editor, Senior Moderator
Transl Res
. 2021 Dec 22;S1931-5244(21)00304-2.
doi: 10.1016/j.trsl.2021.12.007. Online ahead of print.
Messenger Ribonucleic Acid Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2 - A Review
Christine M Akamine[SUP] 1 [/SUP], Hana M El Sahly[SUP] 2 [/SUP]
Affiliations
Abstract
The mRNA therapeutics have been studied since the 1970s and the currently available mRNA vaccines against COVID-19 are the culmination of decades of scientific research. The mRNA vaccines BNT162b2 and mRNA-1273 have played a key role in our global response to the COVID-19 pandemic as they have demonstrated significant advantages over conventional vaccines and have proven to be highly effective against COVID-19 associated hospitalization and severe illness in large clinical trials and studies using real-world data.
Keywords: Covid-19; mRNA; review; vaccine.
. 2021 Dec 22;S1931-5244(21)00304-2.
doi: 10.1016/j.trsl.2021.12.007. Online ahead of print.
Messenger Ribonucleic Acid Vaccines for Severe Acute Respiratory Syndrome Coronavirus-2 - A Review
Christine M Akamine[SUP] 1 [/SUP], Hana M El Sahly[SUP] 2 [/SUP]
Affiliations
- PMID: 34954088
- DOI: 10.1016/j.trsl.2021.12.007
Abstract
The mRNA therapeutics have been studied since the 1970s and the currently available mRNA vaccines against COVID-19 are the culmination of decades of scientific research. The mRNA vaccines BNT162b2 and mRNA-1273 have played a key role in our global response to the COVID-19 pandemic as they have demonstrated significant advantages over conventional vaccines and have proven to be highly effective against COVID-19 associated hospitalization and severe illness in large clinical trials and studies using real-world data.
Keywords: Covid-19; mRNA; review; vaccine.